Statin Therapy in Patients with Type 2 Diabetes Mellitus in Hungary
Journal Title: Cardiology and Angiology: An International Journal - Year 2015, Vol 4, Issue 4
Abstract
Aim: The benefit of statin administration in the secondary prevention of cardiovascular diseases in type 2 diabetes mellitus (T2DM) is well documented. The aim of the study was to evaluate the characteristics of lipid lowering therapy and the attainment of target values. Study Design: Retrospective data analysis. Place and Duration of Study: Between 2009 and 2011, Hungary. Methodology: The study was conducted on the patients with T2DM and established cardiovascular events of general practitioners and specialists from the MULTI GAP (MULTI Goal Attainment Problem) survey in Hungary using standardized, structured questionnaires. Data collection was performed in 2009 (1582 patients, 55.0% men), in 2010 (1159 patients, 58.4% men) and in 2011 (668 patients, 59.1% men). Results: In this study all patients received statins, the most frequently used was atorvastatin, followed in 2009 by simvastatin and 2011 by rosuvastatin. Fibrates were taken by 9.3–11.3% of patients and ezetimibe by 8.0–15.9% of patients. The total cholesterol (TC) values in 2009, in 2010 and in 2011 were 5.27±1.23 mmol/l, 4.90±1.30 mmol/l, 4.88±1.29 mmol/l, respectively (p>0.05). The LDL-cholesterol (LDL-C) values were 2.94±1.04 mmol/l, 2.73±0.95 mmol/l, 2.69±1.03 mmol/l, respectively (p>0.05). The proportion of patients at LDL-C target value of <2.5 mmol/l was 35.2%, 42.8%, 47.8% (p<0.001 vs values in 2009) while that of <1.8 mmol/l was 10.6%, 15.9% and 16.8%, respectively (p<0.001 vs values in 2009). There was a linear correlation between the patient compliance estimated by the physicians and the LDL-C achievement rate. Conclusions: In 2009-2011, a slight improvement in serum cholesterol levels and a significant increase of patients at target TC or LDL-C values were documented among patients with T2DM and cardiovascular diseases. Nevertheless, the authors find very important to improve the quality of lipid lowering treatment in order to increase the number of patients achieving their target lipid values.
Authors and Affiliations
Laszlo Mark, Istvan Reiber, György Paragh, Gyula Pados, Zoltan Kiss
Keywords
Related Articles
- EP ID EP344083
- DOI 10.9734/CA/2015/22424
- Views 106
- Downloads 0
Coronary Spasm as a Cause of Recurrent Chest Pain: A Case Report
Background: Coronary artery spasm plays an important role in the pathogenesis of a wide variety of ischemic heart diseases, including myocardial infarction and sudden cardiac death. However, the diagnosis of vasospastic...
Comparison of In-Hospital Outcome of Acute Myocardial Infarction in Patients with vs without Diabetes Mellitus in Durres Population
Background: Diabetes mellitus (DM) is a worldwide epidemic and a major public health problem and the mortality of diabetic patients is twice higher than that of with non-diabetic patients. The in-hospital outcomes in dia...
Severe Coronary Artery Ectasia with ST Elevation MI: A Challenging Situation
Aim: To report a case of huge coronary artery ectasia presenting with acute myocardial infarction; a relatively rare finding encountered during coronary angiography. Presentation of Case: A young male presented with ches...
Early or Selective Invasive Strategy in Patients with Non-ST-segment Elevation Acute Coronary Syndrome According to the Risk Factors at Presentation? An Outcome Study
Aims: Patients with acute coronary syndrome without ST segment elevation are a heterogeneous group with respect to the risk of having a major adverse cardiac event (MACE). History of diabetes mellitus (DM), chronic kidne...
A Four-year Study of Chronic Patients’ Information Integration in Dental and Medical Documentation in a Secondary Care Setting
Integrated health documentation captures, imports and exports relevant extract of patient’s longitudinal health information record. Especially documenting patients’ chronic disease data in dental documentation system is...